Biliary stent LIFESTENT® and LIFESTENT® XL

biliary stent
biliary stent
Add to favorites
Compare this product




Features: Longest lesion length indication (up to 240 mm) Unique helical design Engineered for bending, compression, torsion Dynamic vessel conformability Improved lesion coverage with a single stent A single-arm, prospective, non-randomized, multi-center study evaluating the safety and effectiveness of the LIFESTENT® SOLO™ in the treatment of symptomatic vascular disease of the SFA and/or proximal popliteal artery. Subjects were treated with conventional PTA followed by implantation of the Bard LIFESTENT® Vascular Stent. TRIAL OVERVIEW Q 76 patients Q 7 study sites in Germany Q Symptomatic de-novo or restenosed lesions Q Average lesion length of 91 mm *The LIFESTENT® Vascular Stent System and the LIFESTENT® SOLO™ Vascular Stent System are intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions up to 240 mm in length in the native superficial femoral artery (SFA) and popliteal artery with reference vessel diameters ranging from 4.0-6.5 mm. † The LIFESTENT® 5 mm diameter was not included in the LIFESTENT® 200 mm Trial.


No catalogs are available for this product.

See all of Bard Medical‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.